The Jenner Institute is a research partnership between the University of Oxford and The Pirbright Institute.
The Institute focuses on the parallel development of human and vetinary vaccines against major global diseases - from early-stage research through to clinical trials.
Professor Ellie Barnes, Jenner Investigator and leader of the Hepatitis C vaccine programme at the University of Oxford, talks to Jack Stewart, 'Science in Action', BBC World Service.
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Dr John Reynolds / Prof Helen McShane: Acute General Medicine Firm B / The Jenner Institute, 27 Nov 13:00
Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model. J Infect Dis
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory. Sci Transl Med , 6 (261)
Complete genomic sequence of KIR3DL1*0150102. Tissue Antigens